$61.9M in total Medicare payments across 2 years
Procedure 0340U (Dna assays for detection of minimal residual disease in cancer) received $61.9M in total Medicare payments.
Across 16.1K services, the average Medicare payment was $3.8K per service.
CA leads in spending on this procedure, accounting for 86% of all payments.
AI-generated analysis based on Medicare payment data.
| Year | Payments | Services | YoY Change |
|---|---|---|---|
| 2022 | $9.0M | 2.4K | — |
| 2023 | $52.9M | 13.8K | +490.1% |
| # | Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|---|
| 1 | Natera, Inc. | Clinical Laboratory | CA | $52.9M | 13.8K | $3.8K |
| State | Payments | Services | Providers | Avg/Provider |
|---|---|---|---|---|
| CA | $52.9M | 13.8K | 1 | $52.9M |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.